Diagnostic imaging  

Revolutionary lung imaging technology, vibration response imaging (VRI), available in EU

20 September 2005

Brussels, Belgium & Or-Akiva, Israel. A new technology for imaging lungs, vibration response imaging, has been approved for use in the EU. Vibration Response Imaging (VRI) provides a dynamic image of the lungs, delivering both structural and functional information to aid in assessing lung condition.

Deep Breeze Ltd., manufacturer of the VRI(XP)(TM) system, announced that it has received a CE mark, declaring the system "safe and effective" and allowing the company to market the technology to physicians in European Union countries.

"The VRI(XP) system adds a new dimension to interventional pulmonology and evaluation of patients with lung transplants," said Professor Mordechai R. Kramer of Petah-Tikva, Israel. "We will be able to assess lung function much more effectively and non-invasively". Professor Kramer is performing clinical trials at the Pulmonary Institute, Rabin Medical Center affiliated to Sackler School of Medicine, Tel-Aviv University.

The VRI(XP)(TM) system received the CE mark after an audit, which found the device safe and effective to use, and approved it as a lung diagnostic device.

"We are introducing a new imaging technology for the human body, which is radiation-free and organ oriented. Unlike MRI (magnetic resonance imaging), X-ray or Ultrasound, VRI utilizes passive vibration energy that is naturally created in organs to produce a dynamic image of the organ. The development of the first VRI for the lungs was based on the finding that the lung vibration energy directly correlates to the lung airflow. Vibration Response Imaging displays for the first time a dynamic image of the lungs as they function," said Igal Kushnir, MD, CEO and founder of Deep Breeze Ltd. that is based in Or-Akiva, Israel. "The VRI(XP) images expand the physician's understanding of the condition of the lungs hence improving patient management and outcome".

The system is currently being used at sites in Europe, the USA and Israel. The VRI(XP)(TM) system will be on display for the first time in Europe at the European Respiratory Society meeting in Copenhagen, Denmark, September 17-21, 2005.

First deliveries of the VRI(XP) are expected in the fourth quarter of 2005.

To top


To top